BioSpace News Archive

The Onyx™ platform enables scientists to create libraries of millions of precisely engineered single cells in one experiment through a fully automated workflow

World leader in breast cancer screening celebrates recent portfolio expansion to address the entire continuum of breast cancer diagnosis and care

Genomind®, a leading mental health company bringing precision medicine into mainstream mental health treatment, and DrChrono, a company enabling the medical practice of the future, are expanding their partnership to meet the growing need of mental health patients and healthcare providers to integrate personalized genetic tests into electronic medical records.

Optical retailer launches lightweight, sophisticated men’s glasses inspired by vintage aircraft

WellCare Health Plans, Inc. and Care1st Health Plan Arizona, a WellCare company, announced the WellCare Community Foundation has donated $250,000 to Kids Aid, Inc., an Arizona-based nonprofit.

Heron Therapeutics, Inc. announced that it has resubmitted its New Drug Application to the U.S. Food and Drug Administration for HTX-011, an investigational agent for the management of postoperative pain.

Leading patient engagement solution provider Qure4u announces a new affiliation with Unified Women’s Healthcare, a large, multi-state organization dedicated to advancing the transformation of women’s healthcare in the United States.

BioMarin Pharmaceutical Inc. announced that Robert Baffi, Ph.D., President of Global Manufacturing and Technical Operations, will participate in a fireside discussion at the Jefferies Gene Therapy/Editing Summit on October 8, 2019 at 11:15am ET in New York.

Introductory special includes giveaway of one free episode along with promotional pricing of only $49

Immunicom, Inc., a medical technology company that has been awarded FDA Breakthrough Device Designation for its non-pharmaceutical solution for treating stage IV metastatic cancer, gained an additional $1.85 million towards its Series B investment round on September 9th.